Experimental cancer drug enters first human testing
NCT ID NCT06597721
Summary
This is the first human study of an experimental cancer drug called ADCE-T02 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will test different doses in 210 participants to find the safest amount and see how the body processes the drug. The main goals are to determine the maximum safe dose and check for side effects, while also looking for early signs that the drug might help control cancer growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cabrini Hospital
RECRUITINGMalvern, Victoria, 3144, Australia
-
Highlands Oncology Group
RECRUITINGRogers, Arkansas, 72758, United States
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 6009, Australia
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Peninsula and South Eastern Haematology and Oncology Group (PSEHOG)
RECRUITINGFrankston, Victoria, 3199, Australia
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
Scientia Clinical Research
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Southern Oncology Clinical Research Unit
RECRUITINGBedford Park, South Australia, 5042, Australia
-
Yale University Cancer Center
RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.